Evidence map›Paper›PMID 35545288›Full record

ArticleBMJ global health2022

Knowledge translation and evidence generation to increase the impact of vector control in Burkina Faso, Cameroon and Malawi.

Chikondi Andrew Mwendera, Themba Mzilahowa, Flobert Njiokou, Sagnon N'falé, Jessica Amegee Quach, Edward Thomsen, Roch Dabire, Hilary Ranson, Nurudeen Alhassan, Rose Oronje and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Chikondi Andrew MwenderaVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID 0000-0003-1513-7088
Themba MzilahowaMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Flobert NjiokouCentre for Research in Infectious Diseases, Yaoundé, Cameroon.
Sagnon N'faléCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Jessica Amegee QuachCentre for Capacity Research, International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Edward ThomsenVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Roch DabireInstitut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
Hilary RansonVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Nurudeen AlhassanAfrican Institute for Development Policy, Lilongwe, Malawi.
Rose OronjeAfrican Institute for Development Policy, Nairobi, Kenya.
Eve WorrallVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK eve.worrall@lstmed.ac.uk.ORCID 0000-0001-9147-3388
Liverpool School of Tropical Medicine · GBAfrican Institute for Development Policy · MWAfrican Institute for Development Policy · KECentre National de Recherche et de Formation sur le Paludisme · BFInstitut de Recherche en Sciences de la Santé · BFKamuzu Central Hospital · MWMinistry of Scientific Research and Innovation · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lack of context-specific evidence and inadequate evidence-use for decision-making contribute to poor health. This paper reports on our work aimed at addressing the knowledge translation (KT) gap between evidence generators and users. We present our experiences of strengthening KT via technical advisory groups (TAGs) in parallel with increasing evidence generation through research fellowships and operational research. Vectorborne diseases (VBDs) impose substantial health and economic burdens in sub-Saharan Africa despite being preventable with vector control. The Partnership for Increasing the Impact of Vector Control aimed to reduce the burden of VBDs in Burkina Faso, Cameroon, Malawi and at regional and global levels. TAGs can promote evidence-use in policy and practice by engaging relevant stakeholders in both research and policy processes. TAGs and related activities are best facilitated by a coordinator with skills in research and policy. Contextual factors should influence the design and governance of TAGs, which will likely evolve over time. Relevant national stakeholders should be included in TAGs and be actively involved in developing research agendas to increase the relevance and acceptability of research findings for decision-making. The countries present three differing contexts with longer-term research and evaluation necessary to draw lessons on impact.

Indexed as

Translational Science, BiomedicalBurkina FasoCameroonHumansMalawiControl strategiesHealth policyPublic Health

Identifiers

PMID35545288
PMCPMC9096501
OpenAlexW4280567866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.